title: Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination.
abstract: Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is up-regulated in the neointima of remodeling arteries and modulates vascular smooth muscle cell (VSMC) growth. Platelet-derived growth factor (PDGF) is the prototypic growth factor for VSMCs and plays a key role in vascular remodeling. Here, we sought to further define ESDN function in primary human VSMCs. ESDN down-regulation by RNA interference significantly enhanced PDGF-induced VSMC DNA synthesis and migration. This was associated with increased ERK1/2, Src, and PDGF receptor (PDGFR)beta phosphorylation, without altering total PDGFRbeta expression levels. In binding assays, ESDN down-regulation significantly increased (125)I-PDGF maximum binding (B(max)) to PDGF receptors on VSMCs without altering the binding constant (K(d)), raising the possibility that ESDN regulates PDGFR processing. ESDN down-regulation significantly reduced ligand-induced PDGFRbeta ubiquitination. This was associated with a significant reduction in the expression level of c-Cbl, an E3 ubiquitin ligase that ubiquitinylates PDGFRbeta. Thus, ESDN modulates PDGF signaling in VSMCs via regulation of PDGFR surface levels. The ESDN effect is mediated, at least in part, through effects on PDGFRbeta ubiquitination. ESDN may serve as a target for regulating PDGFRbeta signaling in VSMCs.
authors.affiliation: Cardiovascular Molecular Imaging Laboratory, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
authors.forename: Xiaojia
authors.initials: X
authors.lastname: Guo
authors.forename: Lei
authors.initials: L
authors.lastname: Nie
authors.forename: Leila
authors.initials: L
authors.lastname: Esmailzadeh
authors.forename: Jiasheng
authors.initials: J
authors.lastname: Zhang
authors.forename: Jeffrey R
authors.initials: JR
authors.lastname: Bender
authors.forename: Mehran M
authors.initials: MM
authors.lastname: Sadeghi
mesh_terms: D002478:Cells, Cultured; D015536:Down-Regulation / Q000502:physiology*; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism*; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D032389:Myocytes, Smooth Muscle / Q000378:metabolism*; D010766:Phosphorylation / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D050721:Proto-Oncogene Proteins c-cbl / Q000378:metabolism; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism; D054875:Ubiquitination / Q000502:physiology; D019061:src-Family Kinases / Q000378:metabolism
chemical_list: C436326:DCBLD2 protein, human; D008565:Membrane Proteins; D010982:Platelet-Derived Growth Factor; D050721:Proto-Oncogene Proteins c-cbl; D044767:Ubiquitin-Protein Ligases; D020797:Receptor, Platelet-Derived Growth Factor beta; D019061:src-Family Kinases; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; C067419:CBL protein, human
references.citation: Arterioscler Thromb. 1993 Aug;13(8):1218-26
references.pmid: 8343497
references.citation: Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):795-801
references.pmid: 12637337
references.citation: J Biol Chem. 1993 Jan 5;268(1):577-83
references.pmid: 8380168
references.citation: Platelets. 2001 Sep;12(6):352-8
references.pmid: 11672474
references.citation: Science. 1999 Oct 8;286(5438):309-12
references.pmid: 10514377
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2946-51
references.pmid: 15710889
references.citation: Am J Physiol Cell Physiol. 2007 Jan;292(1):C59-69
references.pmid: 16956962
references.citation: Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2597-605
references.pmid: 17951322
references.citation: J Biol Chem. 1993 Oct 15;268(29):21478-81
references.pmid: 7691811
references.citation: J Biol Chem. 2007 Dec 28;282(52):37815-25
references.pmid: 17971444
references.citation: J Biol Chem. 1999 Jun 4;274(23):16619-28
references.pmid: 10347229
references.citation: Circ Res. 2007 Sep 28;101(7):672-81
references.pmid: 17704212
references.citation: J Biol Chem. 2007 Oct 5;282(40):29336-47
references.pmid: 17620338
references.citation: Curr Opin Cell Biol. 1995 Apr;7(2):176-82
references.pmid: 7612268
references.citation: Biochem Soc Trans. 2004 Jun;32(Pt3):443-6
references.pmid: 15157156
references.citation: J Biol Chem. 2001 Sep 7;276(36):34105-14
references.pmid: 11447234
references.citation: J Cell Biol. 1996 Feb;132(4):741-52
references.pmid: 8647902
references.citation: Physiol Rev. 2004 Jul;84(3):767-801
references.pmid: 15269336
references.citation: Cell Signal. 2006 Jul;18(7):971-81
references.pmid: 16214305
references.citation: Mol Cell Biol. 2004 Mar;24(5):2190-201
references.pmid: 14966296
references.citation: Circ Res. 2004 May 14;94(9):1219-26
references.pmid: 15059930
references.citation: Am J Physiol Cell Physiol. 2007 Feb;292(2):C886-95
references.pmid: 16987998
references.citation: Am J Transplant. 2007 Sep;7(9):2098-105
references.pmid: 17697260
references.citation: J Biol Chem. 1995 Dec 8;270(49):29447-52
references.pmid: 7493983
references.citation: J Cell Physiol. 2006 Oct;209(1):21-43
references.pmid: 16741904
references.citation: Surgery. 1997 Aug;122(2):138-44; discussion 144-5
references.pmid: 9288116
references.citation: Oncogene. 2002 Apr 25;21(18):2822-8
references.pmid: 11973641
references.citation: J Biol Chem. 1992 Mar 25;267(9):6429-34
references.pmid: 1313434
references.citation: Mol Cancer Res. 2008 Feb;6(2):222-30
references.pmid: 18314483
references.citation: EMBO J. 1997 Sep 15;16(18):5600-7
references.pmid: 9312019
references.citation: Genes Dev. 2008 May 15;22(10):1276-312
references.pmid: 18483217